Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
A strategic thought partner for your AI journey
Explore our latest insights and perspectives in these life science resources, news articles, and events.
Introduction The 2024 American Society of Hematology (ASH) Annual Meeting presented a wealth of data, unveiling the...
Putnam shares key questions to consider in preparation of advancing trials and deals that have been put on hold.
Putnam has a proven track record of delivering superior strategic support to pharma leaders in developing strategies...
Putnam's Demand Calibration Tool enhances demand estimation accuracy by leveraging insights from 200+ studies across 50+ diseases and markets
We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.
Putnam experts share observations on recent global trends in the rare disease space and recommend strategies to maximize opportunities.
Personalized medicine is revolutionizing the field of oncology, and gastrointestinal (GI) cancers are at the forefront of this exciting development.
Our experts shared key themes for #ASCO24 and now summarize the vital insights on antibody drug conjugates, radiopharmaceuticals, and bispecifics.
The Inflation Reduction Act (IRA) is likely to prompt a range of second-order effects on the pharmaceutical industry...
In recent years, we have observed increasing clinical development activity in autoimmune diseases, including for Myasthenia Gravis (MG).
Our experts take a deep dive into the growing oncology market uncovering the top drivers and activities of revenue growth.
Targeted radiopharmaceuticals are transforming cancer treatment and may become the ultimate focal therapy.
Looking to get in touch with an expert or team member?
Tell us how we can help.
